Search results

...dence Based Practice (EBP)]] in the health sciences, objective measures of outcome are important to provide credible and reliable justification for treatment. ...otherapists in the United Kingdom makes it clear that standardised outcome measures should be used routinely in normal practice:

...treatment evaluations. These tools provide an [[Outcome Measures|objective outcome]], and need be accurate and of high quality.<ref name=":0">Albanese A, Sorb ...f existing rating scales eg to include non motor features, and new outcome measures for dystonia's that currently have no rating scales eg. lower limb and trun

...linical MRI using 18F-FDG PET imaging: A preliminary report]. Frontiers in Neurology. 2022 Sep 15;13:844911.</ref><br> == Outcome Measures ==

...isk categorization of the patient. Prior to providing any intervention, an outcome measure provides baseline data. The initial results may help determine the ...lassman SD. [https://www.ncbi.nlm.nih.gov/pubmed/28753065 Patient-reported outcome scores underestimate the impact of major complications in patients undergoi

...abilitation."<ref>Alreni AS, McRobert C, McLean SM. Utilisation of outcome measures in the management of non-specific neck pain: a national survey of current p Outcome measures that are used in clinical practice include:

...le (GDS) is a [[Patient Reported Outcome Measures (PROMs)|patient-reported outcome measure]] created by Yesavage et al. in 1982 to screen for depressive sympt ...riatric Depression Scale in depression in Parkinson’s disease]. Journal of Neurology, Neurosurgery & Psychiatry. 2005 Oct 1;76(10):1445-7.</ref>

...ogress in Children with Limited Ambulation. European Journal of Paediatric Neurology. 2003;7(4):155–9. pmid:12865054</ref> The Hammersmith Functional Motor Sc [[Category:Outcome Measures]]

The '''Fatigue Severity Scale (FSS)''' is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifesty ...e="Grace et al">Grace, J., Mendelsohn, A., et al. "A comparison of fatigue measures in Parkinson's." Parkinsonism Relat Disord 2007 13(7): 443-445</ref>

...or member of the clinical staff scores the patient on the items that this outcome measure addresses. Ideally the information obtained for scoring would be th <br> Equipment is not needed to perform and utilize this outcome measure.<ref name=":1">The Spinal Cord Independence Measure (SCIM). Availab

...5.6557&rep=rep1&type=pdf Parkinsonism: onset, progression, and mortality]. Neurology. 1998 Feb 1;50(2):318-.</ref>. In 1983 Larsen et al. <ref>Larsen TA, LeWitt ...trials to define inclusion and exclusion criteria, but not typically as an outcome measure.

...the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–1720.</ref> ...veness of different rating instruments in spinocerebellar ataxia patients. Neurology. 2010 23;74(8):678-84.</ref><ref name="Ataxia uk">Ataxia UK. Management of

== Outcome Measures == (see [[Outcome Measures|Outcome Measures Database]])

...mead Mobility Index. Available from: https://www.sralab.org/rehabilitation-measures/rivermead-mobility-index (Accessed 23/06/2022)</ref>. ...obility index and modified functional ambulation classification as outcome measures for Chinese stroke patients]. Physiother Theory Pract. 2014 Jul;30(5):353-9

...al seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology. 1994 Jul;44(7):1198-202</ref><ref>Teller DC1, Murphy TP, Bilateral facial == Outcome Measures ==

...Mackey, F. M. Motor assessment scale scores as a measure of rehabilitation outcome following stroke. Aust J Physiother. 1992; 38, 31-35.</ref><ref>Carr JH, Sh ...by Carr and Shepherd (1985) based on many years of experience with similar measures<ref name="p2" />

...ke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)]. Neurology July 1, 1999 vol. 53 no. 1 126</ref><ref>Runde D. [https://pubmed.ncbi.nlm. ...rce use after acute hospitalization: the Northern Manhattan Stroke Study]. Neurology. 2000 Oct 24;55(8):1180-7</ref>:

...B. M. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336539/#CR40 Outcome Measures in Clinical Trials for Multiple Sclerosis.] CNS drugs. 2017;31(3):217–236 |PASAT was originally included to cover the cognitive domain. It measures processing speed and working memory(concentration, speed of auditory, infor

...ence/article/pii/B9780323057127000088 Myelopathies]. In: Rolak, AL editor. Neurology Secrets (Fifth Edition). Mosby 2010. p131-140.</ref>. This is due to the le == Outcome Measures ==

...considering the reliability, validity, or responsiveness of the particular outcome measure. However, some of those measurement tools were commonly used by phy |Diagnostic Measures of Body Function and Structure Indicating “Red Flags” or “Yellow Flag

...rticles/PMC2898886/ Progress in periventricular leukomalacia]. Archives of neurology. 2008 Oct 13;65(10):1291-5.</ref> ...confined to the GM generally do not have a major effect on the prognostic outcome. When bleeding extends into the ventricles, hydrocephalus may result. If th